Unable to load price data. Sorry.

¯\_(ツ)_/¯

Insys Therapeutics (NASDAQOTH:INSYQ)

CAPS Rating: 2 out of 5

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

56 Outperform
9 Underperform
 

All-Star Players

10 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTH:INSYQ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

crashchandler (< 20)
Submitted March 05, 2014

This company has created a new business plan to have this medication authorized by the insurance companies at the home office of INSY and taken it out of the hands of the perscribing physicians. This has enabled the company to have more… More

zzlangerhans (99.02)
Submitted June 29, 2015

This is a rising knife stock if ever there was one, so don't expect this to be a real world position any time soon. More than 99% of Insys revenues come from a single drug, Subsys, which is a sublingual spray of the potent opiate fentanyl. If… More

NASDAQOTH:INSYQ VS S&P 500 (SPY)

NASDAQOTH:INSYQ Summary

Fools bullish on NASDAQOTH:INSYQ are also bullish on:

Fools bearish on NASDAQOTH:INSYQ are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INSYQ.

Recs

0
Member Avatar airenInDebt (77.41) Submitted: 9/15/2018 2:16:47 PM : Outperform Start Price: $8.44 NASDAQ OTHER:INSYQ Score: -110.04

The focus on CBD related medicines will eventually propel this stock.

Recs

0
Member Avatar AriGold212855 (67.74) Submitted: 5/12/2017 2:14:54 PM : Underperform Start Price: $11.74 NASDAQ OTHER:INSYQ Score: +135.68

Based on "flopped" earnings and no new products slated till later in the year.

Recs

0
Member Avatar DeepEnds (< 20) Submitted: 9/25/2014 12:40:38 PM : Outperform Start Price: $18.03 NASDAQ OTHER:INSYQ Score: -166.17

The company, which is already highly profitable, is ready to release a THC medication marketed as an alternative to Marinol. Trials have shown that it is tolerated far better by patients than Marinol.

Leaderboard

Find the members with the highest scoring picks in INSYQ.

Score Leader

JDusan

JDusan (89.46) Score: +221.14

The Score Leader is the player with the highest score across all their picks in INSYQ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
armycommando 56.94 4/16/2014 Underperform 5Y $18.66 -98.44% +77.96% +176.40 0 Comment
CocaineOrStock 98.46 7/15/2014 Underperform 5Y $12.79 -97.72% +67.26% +164.98 0 Comment
barrywstone 29.57 7/29/2014 Underperform NS $14.63 -98.01% +66.55% +164.56 0 Comment
whatthree16 69.84 12/4/2014 Underperform 5Y $19.07 -98.47% +59.03% +157.51 0 Comment
carmendarez < 20 12/22/2016 Underperform 5Y $9.26 -96.86% +46.30% +143.16 0 Comment
chushogi 65.39 12/13/2016 Underperform 5Y $9.17 -96.83% +45.39% +142.21 0 Comment
AriGold212855 67.74 5/12/2017 Underperform 1Y $11.74 -97.52% +38.16% +135.68 1 Comment
divingfalcon < 20 6/12/2017 Underperform 5Y $11.35 -97.44% +35.75% +133.19 0 Comment
OttoBismarck 99.91 12/18/2018 Underperform 5Y $4.30 -93.23% +29.45% +122.68 0 Comment
airenInDebt 77.41 9/17/2018 Outperform 1Y $8.44 -96.55% +13.49% -110.04 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INSYQ.